Millennium Management LLC raised its holdings in National Research Co. (NASDAQ:NRC - Free Report) by 200.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 214,858 shares of the company's stock after acquiring an additional 143,454 shares during the period. Millennium Management LLC owned about 0.90% of National Research worth $4,931,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the business. Kayne Anderson Rudnick Investment Management LLC boosted its position in shares of National Research by 0.6% during the second quarter. Kayne Anderson Rudnick Investment Management LLC now owns 3,045,306 shares of the company's stock worth $69,890,000 after buying an additional 18,891 shares during the period. Vanguard Group Inc. boosted its position in shares of National Research by 1.1% during the first quarter. Vanguard Group Inc. now owns 944,995 shares of the company's stock worth $37,431,000 after buying an additional 10,351 shares during the period. Renaissance Technologies LLC boosted its position in shares of National Research by 14.4% during the second quarter. Renaissance Technologies LLC now owns 432,884 shares of the company's stock worth $9,935,000 after buying an additional 54,600 shares during the period. Norden Group LLC acquired a new position in shares of National Research during the first quarter worth about $5,170,000. Finally, Bank of New York Mellon Corp boosted its position in National Research by 5.4% during the second quarter. Bank of New York Mellon Corp now owns 123,255 shares of the company's stock valued at $2,829,000 after purchasing an additional 6,295 shares during the last quarter. 47.26% of the stock is owned by institutional investors and hedge funds.
National Research Stock Up 0.8 %
NASDAQ NRC traded up $0.15 during trading hours on Friday, hitting $18.86. 56,157 shares of the company traded hands, compared to its average volume of 87,296. The business's 50-day moving average is $21.45 and its 200-day moving average is $26.39. National Research Co. has a twelve month low of $18.70 and a twelve month high of $44.60. The company has a debt-to-equity ratio of 0.64, a quick ratio of 0.37 and a current ratio of 0.37. The stock has a market capitalization of $450.32 million, a price-to-earnings ratio of 15.21 and a beta of 0.49.
National Research (NASDAQ:NRC - Get Free Report) last issued its quarterly earnings results on Tuesday, August 6th. The company reported $0.26 EPS for the quarter. National Research had a return on equity of 63.64% and a net margin of 20.01%. The firm had revenue of $35.02 million during the quarter.
National Research Dividend Announcement
The firm also recently disclosed a quarterly dividend, which was paid on Friday, October 11th. Shareholders of record on Friday, September 27th were paid a $0.12 dividend. The ex-dividend date was Friday, September 27th. This represents a $0.48 annualized dividend and a yield of 2.55%. National Research's dividend payout ratio is 38.71%.
National Research Company Profile
(
Free Report)
National Research Corporation provides analytics and insights that facilitate measurement and enhancement of the patient and employee experience. Its portfolio of subscription-based solutions provides actionable information and analysis to healthcare organizations across a range of mission-critical, constituent-related elements, including patient experience, service recovery, care transitions, employee engagement, reputation management, and brand loyalty.
Read More
Before you consider National Research, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and National Research wasn't on the list.
While National Research currently has a "hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.